Trust Company’s Idexx Laboratories IDXX Stock Holding History

Trust Company’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$526	Hold	1	–	–	﹤0.01%	740
2026 Q1	$562	Hold	1	–	–	﹤0.01%	675
2025 Q4	$677	Buy	+1	New	+$681	﹤0.01%	611

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Trust Company's IDXX Position: Q2 2026 in Review

Trust Company held its Idexx Laboratories (IDXX) position steady in Q2 2026 at 1 share worth $526. The position accounts for ﹤0.01% of the portfolio, ranked #740.

Trust Company first reported a position in IDXX in Q4 2025 and has held it in 3 quarters since. The position peaked at $677 in Q4 2025. 1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

Trust Company held 1 share of Idexx Laboratories worth $526 as of Q2 2026.
Trust Company left its Idexx Laboratories share count unchanged in Q2 2026.
Idexx Laboratories made up ﹤0.01% of Trust Company's portfolio in Q2 2026, its #740 holding.
Trust Company first reported a position in Idexx Laboratories in Q4 2025 and has held it in 3 quarters since.
Trust Company's Idexx Laboratories position peaked at $677 in Q4 2025.
1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Trust Company's 13F filing for Q2 2026, filed 10 Jul 2026.